Kenneth Howard Warrington Jr.
CIK: 0002147208
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)2 (100.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BSEM
BioStem Technologies, Inc.
Director
Discretionary Trading P&L
Holdings
About WARRINGTON KENNETH HOWARD JR
WARRINGTON KENNETH HOWARD JR (SEC CIK 0002147208) files insider reports with the SEC as Director of BioStem Technologies, Inc. (BSEM).
Signal8 holds 3 ownership filings by WARRINGTON KENNETH HOWARD JR (1 Form 3, 2 Form 4), filed between Aug 14, 2026 and Sep 17, 2026. Those filings report 2 transactions, from Aug 27, 2026 to Sep 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on WARRINGTON KENNETH HOWARD JR's filings is in POMPANO BEACH, FL.
Recent filings by WARRINGTON KENNETH HOWARD JR
Other insiders filing for BioStem Technologies, Inc. (BSEM)
- SMITH-VAN VURST ANDREW, Chief Operating Officer
- Matuszewski Jason, Chief Executive Officer
- POE BRANDON, Chief Financial Officer
- FORTUNATO MICHAEL A, Chief Accounting Officer
- HASSETT BARRY, Chief Commercial Officer
- UNGRODT JODI, Director